CStone Pharmaceuticals Schedules Key Board Meeting
Company Announcements

CStone Pharmaceuticals Schedules Key Board Meeting

CStone Pharmaceuticals (HK:2616) has released an update.

CStone Pharmaceuticals has announced a board meeting scheduled for August 23, 2024, to discuss and approve its unaudited interim financial results for the first half of the year and to consider declaring an interim dividend. The meeting will be an important event for the company and its subsidiaries as they evaluate their mid-year financial performance.

For further insights into HK:2616 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App